Overview: This research study compares the study medicine, Zenagamtide, with insulin glargine in people with type 2 diabetes, to evaluate blood-sugar control, body weight, safety, including cardiovascular outcomes. Participants will be 45 years or older, male or female, and diagnosed with type 2 diabetes at least 6 months ago.
Overview: This research study is designed to investigate the potential effect of the study medicine in lowering the risk of future cardiovascular complications
Overview: The trial is designed to evaluate the safety of CNP-103 and explore if it may help protect insulin-producing beta cells that support better blood sugar control. Participants will be 12 - 35 years old, male or female, and diagnosed with Stage 3 T1D within the last 6 months.
Overview: This clinical trial will study how safe and effective a new drug is for children and adolescents with certain growth conditions. Participants will be male and female children between the ages of 2 and 18.
Overview: This global study evaluates the effectiveness of combining an investigational medicine with empagliflozin in reducing serious heart health events.
Overview: This study evaluates the safety and effectiveness of a medication aiming to preserve function of insulin producing cells. Participants will be ages 1 to 25, male or female.
Overview: Evaluation of the Fully Closed Loop Omnipod® System for Safety and Efficacy in Adults with Type 2 Diabetes.
Overview: You could be part of a clinical study programme that helps get more information on how a new, once-weekly insulin product, helps in reducing the blood sugar compared with insulin products taken once daily.
Overview: This study aims to help us learn about growth in children with idiopathic short stature and does not involve any study drugs or treatments.
Overview: This study is testing an investigational study drug in people recently diagnosed with type 1 diabetes.
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
